Startup based in the United States, most recent round Series-c-plus, 2 tracked investors.
BridgeBio is a startup founded in 2015 based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
BridgeBio is a biopharmaceutical company that discovers, finances and develops targeted medicines for patients with genetic diseases and cancers. It advances drug candidates from discovery through clinical development and regulatory processes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.